Analyze, Deliver, Measure and Communicate Value at Every Stage of the Product Lifecycle. Meet us at ISPOR Copenhagen, November 2-6, 2019 Booth # C3-057 EVERSANA proudly announces our participation at ISPOR Copenhagen, taking place from November 2-6. ISPOR is the leading global conference for Health Economics and Outcomes Research. This year’s conference theme – Digital […]
Please join the EVERSANA team in Atlanta GA, as we discuss challenges that access teams face today and looking into the future on topics such as: Rationalizing gross-to-net Speeding time to therapy Improving patient adherence Optimizing product distribution, market access, and patient access On Tuesday, October 21 at 2:30 pm EST, Tom Doyle, SVP of […]
Improving the lives of people with rare diseases. The National Organization for Rare Disorders (NORD®), an independent nonprofit, is leading the fight to improve the lives of rare disease patients and families. NORD is committed to accelerating research, raising awareness, providing valuable information and driving public policy that benefits the millions of Americans impacted by […]
As the largest gathering of rare disease patients, caregivers, thought leaders and other rare disease stakeholders in the world, the RARE Patient Advocacy Summit is an unparalleled opportunity to forge meaningful connections with other rare advocates and take home actionable strategies and tools to accelerate change. Summit Experience: • A jam-packed, two-day program filled with […]
EVERSANA is attending the CBI’s Outcomes-Based Agreements & Innovative Payer Contracting in Philadelphia, PA from October 2-3. EVERSANA Managing Consultant, Robert Blank, will present his session “Value Based Contracts – Operational Challenges and Best Practices” on Wednesday, October 2 at 4:30 pm. Blank recently wrote a white paper titled, “Pharmaceutical Contracting from Volume to Value” […]
PALO ALTO, Calif. And CHICAGO – September 10, 2019 – Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be ordered, dispensed, and covered by […]
EVERSANA is a proud sponsor of Cell & Gene Meeting on the Mesa, one of the foremost conferences known for bringing together industry leaders to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to […]
EVERSANA is a proud sponsor and panelist of the 5th annual CAR-TCR Summit this September 11-13 in Boston, Massachusetts. The summit brings together more than 1000 global leaders dedicated to innovating, developing and delivering CAR and TCR cell-based immunotherapies to patients across pharma, biotech, regulatory bodies, academia, and solution/service providers. EVERSANA’s General Manager Seth Gordon […]
Meet our team of experts at the NASP Annual Meeting & Expo in Washington, D.C. September 9 – 12, 2019. EVERSANA BOOTH #914 Tuesday, September 10 7:00 am – 8:00 pm Wednesday, September 11 6:00 am – 2:30 pm Disruptive Therapies Call for a Disruptive Business Model Scientific breakthroughs in regenerative therapies are disrupting the […]
Meet us at EPP’s 9th Life Sciences Pricing Forum in Munich, Germany on October 14-16. Schedule a meeting with the EVERSANA Global Pricing Team EVERSANA is particularly pleased to be partnering with the EPP this year as we tackle critical topics for Global Pricing such as: Pricing in a complex eco-system Pricing for new therapies […]